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Adjuncts to eczema care: different 
methodological approaches 
Fiona Cowdell, Professor of Nursing 
and Health Research and NIHR 
Knowledge Mobilisation Research 
Fellow, Associate at the Centre 
of Evidence Based Dermatology, 
University of Nottingham, looks at 
three recently-published papers into 
adjuncts to the treatment of eczema
Background
The quest for acceptable and effective ways of managing eczema goes on. 
The mainstay of treatment is the regular application of topical 
preparations. This can be challenging for patients, parents and children 
alike and it is well known that treatment concordance is hard to achieve. 
There is ongoing interest in non-pharmacological adjuncts to eczema 
care. Investigation of these approaches has been conducted using different 
research methods, each of which has a particular value. This review of three 
recently published papers illustrates how a systematic review, a randomised 
crossover trial and an exploratory qualitative study have contributed to 
knowledge generation around adjuncts to the treatment of eczema
 First study
Citation 
Ridd MJ, King AJL, Le Roux E, Waldecker 
A, Huntley AL. Systematic review of self-
management interventions for people 
with eczema. Br J Dermatol. 177, 719-734 
2017 
Context
Eczema has a high self-management 
demand, but lack of support and 
education for patients and parents of 
children with the condition can lead 
to poor concordance and result in 
treatment failure. Internationally, there 
is increasing recognition that self-
management programmes may be 
helpful but, to date, the active ingredients 
of such programmes are not fully 
understood.  
Methods
A systematic search of the MEDLINE, 
MEDLINE in process, Embase, CINAHL 
and the Global Resource for EczemA 
Trials (GREAT) was conducted to 
identify randomised controlled trials 
published between database inception 
date and August 2016. Twenty studies 
conducted in 11 countries with a total 
of 3,028 participants met the inclusion 
criteria for the review. Data were 
extracted from each paper using a 
bespoke data extraction tool. 
Key fi ndings 
The majority of studies (18/20) were 
secondary care based and focused on 
children with eczema (16/20). Face-
to-face educational interventions were 
most commonly used (13/20), fi ve 
interventions were delivered online 
and two investigated the use of written 
action plans. Reporting of interventions 
and specifi c outcomes was generally 
poor and follow-up was limited to 
12 weeks in 12/20 studies. There was 
inadequate evidence of effectiveness of 
the interventions.
Fiona Cowdell 
we know that effective 
eczema self-management 
needs adequate support
Commentary 
This thorough review has identifi ed a 
lack of high quality, well reported trials of 
eczema self-management interventions. 
Although some interventions show 
promise there remains a gap in 
knowledge about the most clinically 
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and cost effective way to support self-
management of eczema. 
Implications
Intuitively, and from clinical experience as 
nurses, we know that effective eczema 
self-management needs adequate 
support. This review demonstrates that 
new research is needed about the most 
effective approaches. Equally, there is 
a need to accurately and thoroughly 
report the intervention components, for 
which there is now guidance such as the 
TIDieR checklist.1 
 Second study
Citation 
Su JC, Dailey R, Zallmann E et al.
Determining effects of Superfi ne Sheep 
wool in INfantile Eczema (DESSINE): a 
randomised paediatric crossover study. 
Br J Dermatol. 2017, 177:125-133
Context 
Traditionally, people with eczema are 
advised against wearing wool as it is 
often considered to be an irritant. 
Available evidence is outdated, having 
been produced mainly in the 1950s 
when trial reporting standards were less 
rigorous. This trial sought to investigate 
the effect of superfi ne merino wool on 
young children with a SCORing Atopic 
Dermatitis (SCORAD)2 score indicating 
mild-to-moderate eczema.
Methods
A 12-week single centre,
randomised, crossover, prospective 
cohort study involving 39 children aged 
4 weeks to 3 years. Participants were 
initially allocated to wool or cotton 
clothing, and after 6 weeks this was 
swapped for a further 6 weeks. Every 3 
weeks measures of SCORAD, the Atopic 
Dermatitis Severity Index (ADSI)3 and 
the Infants Dermatitis Quality of Life 
(IDQOL)4 scale were recorded by 
assessors who were not aware of which 
clothing the child had been wearing. 
Higher scores on SCORAD and ADSI 
indicate more severe disease and on 
IDQOL point to a greater detrimental 
impact on quality of life. Parents kept a 
diary to record patterns of wear. Eczema 
treatment was standardised to minimise 
confounding variables.
 
Key fi ndings
SCORAD scores reduced for both 
groups from baseline to 12 weeks, 
but the decrease was greater in the 
cotton-fi rst group. Overall, compared 
with baseline wool ensembles were 
associated with a mean SCORAD 
reduction of 2.5 at 3 weeks and 7.6 at 
6 weeks when compared with cotton 
ensembles. A similar pattern was seen 
in ADSI and IDQOL scores. Changing 
from wool to cotton clothing resulted 
in an increase in all scores. Adherence 
to wear for at least 6 hours per day was 
reported by parents in over 85% of days 
in both groups.
Commentary
This is a small Australian-based study 
and fi ndings should be interpreted with 
caution. The authors point to a range 
of reasons that may have infl uenced 
the greater impact of wool ensembles, 
for example differences in the age of 
children in each group, the number of 
visits completed by the cotton-fi rst 
group before swapping to wool, and 
confounding environmental factors. 
 
Implications
This study suggests some improvement 
in skin condition and quality of life when 
using superfi ne merino wool ensembles. 
However, the small sample size, sparse 
information about the garments and 
other confounding factors limit its value. 
Signifi cant further research would be 
needed before any change in current 
practice was considered.
 Third study
Citation 
Wake EV, Batchelor J, Lawton S, Thomas 
KS, Harrison EF, Cowdell FC. The 
experiences of children and young people 
of using silk garments for the treatment of 
eczema: a nested qualitative study within 
the CLOTHES randomised controlled 
trial. Br J Dermatol. Accepted Author 
Manuscript. doi:10.1111/bjd.15909 2017
Context
There is increasing interest in engaging 
children with eczema in both healthcare 
consultations and research. The extent 
to which this happens is variable, and 
traditionally in research children are 
treated as vulnerable and dependent. 
Proxy child reports are often sought 
from parents or practitioners. Research 
is generally conducted “on” rather than 
“with” children with their experiences 
being subsumed by or extrapolated from 
adult views. The Clothing for the Relief 
of Eczema Symptoms (CLOTHES)5,6 trial 
actively engaged children in evaluating 
their experiences of using silk garments 
in a qualitative study nested within a 
randomised controlled trial. 
Methods
In total, 18 children aged 5-15 
participated in focus groups, face-to-face 
interviews or telephone interviews once 
they had completed the randomised 
controlled trial. Parents consented to 
their children participating, and children 
gave their assent either verbally or 
by signing an assent form. Data were 
collected by an experienced child 
nurse researcher. Age appropriate 
activities were designed to help children 
communicate their experiences of using 
the garments. This involved creative 
work and storytelling, as well as more 
traditional research interviews with 
older children. Care was taken to check 
understanding of conversations with, 
and artefacts produced by, the children 
ensure authenticity in portraying their 
experiences.
Key fi ndings
Four key themes were generated 
from the data: expectations of the 
garments; wearing silk garments; 
did they help; and thoughts about 
the garments. Children had high 
hopes for the garments and these 
were not realised, although some 
reported limited improvement in skin 
condition, comfort or wellbeing. They 
were disappointed in the feel of the 
garments, having expected them to feel 
‘silky’ and were aware of deterioration 
in garment condition over time. 
Adherence to wearing the garments 
was variable and children gave specifi c 
and personal explanations for this. This 
study demonstrates that with suffi cient 
planning children can be meaningfully 
engaged in dermatology research 
and that they can offer nuanced and 
particular views that would not be 
elicited from other sources.
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Commentary
This qualitative study was nested within 
a large multi-centre RCT.5, 6 The study 
demonstrates how even young children 
can effectively be engaged in research. 
When combined with other data, such 
as the quantitative RCT results and 
fi ndings from parental qualitative data, 
this work provides a rounded and 
robust evidence-base about the value of 
silk garments in childhood eczema.   
Implications 
This study demonstrates the value of 
qualitative studies nested within RCTs 
to increase confi dence in thoroughness 
of result. More importantly it illustrates 
how children can be engaged in research 
which is so important particularly when 
investigating long-term conditions in which 
the children themselves will be infl uential 
in concordance with therapy.
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LOYON IS EFFECTIVE FOR PLAQUE REMOVAL
Loyon is a gentle keratolytic which has been clinically shown to be as effective 
as 10% salicylic acid for removal of all types of psoriasis plaques, without 
negative side effects.1 A recent study showed that treatment success was 
achieved in three out of four patients with scalp psoriasis in four days.2 
Its fast-acting, non-messy formula is suitable for all ages including babies 
for cradle cap, where it is effective after three treatments.3 Loyon is 
also suitable for elderly psoriasis patients and those who have kidney 
or liver problems.
Loyon’s mode of action is purely mechanical. The advanced creeping 
and spreading properties mean it fl ows into spaces between crusty 
cells, loosening connections between them so that they fall 
away without causing bleeding tear-points. 
The skin is then prepared for treatments such as 
phototherapy, topical steroids, coal tar, calcipotriol, etc.
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Gene to Clinic; 2014 December 11-13; London, UK.
 2. Hengge, U. et al. Single-center, noninterventional clinical trial to assess the safety, effi cacy, and tolerability of a 
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 3. Hengge, U. Topical, Non-Medicated LOYON® in Facilitating the Removal of Scaling in Infants and Children with 
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